251 – 260 of 385
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists
(
- Contribution to journal › Scientific review
-
Mark
MEK1/2 inhibition attenuates vascular ET(A) and ET (B) receptor alterations after cerebral ischaemia.
(
- Contribution to journal › Article
-
Mark
Cooperative effect of angiotensin AT, and endothelin ETA receptor antagonism limits the brain damage after ischemic stroke in rat
(
- Contribution to journal › Article
-
Mark
Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction
(
- Contribution to journal › Article
-
Mark
Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat.
(
- Contribution to journal › Article
-
Mark
Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
(
- Contribution to journal › Article
-
Mark
Vasospasm - Response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats.
(
- Contribution to journal › Article
-
Mark
CGRP-Receptor Antagonism in Migraine Treatment.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A comment
(
- Contribution to journal › Scientific review